Technical Analysis for ENLV - Enlivex Therapeutics Ltd.

Grade Last Price % Change Price Change
F 0.93 10.50% 0.09
ENLV closed up 10.5 percent on Friday, November 22, 2024, on 1.43 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 10.50%
Expansion Breakdown Bearish Swing Setup 10.50%
Lower Bollinger Band Walk Weakness 10.50%
New 52 Week Low Weakness 10.50%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 13 hours ago
Rose Above Lower Bollinger Band about 18 hours ago
Up 5% about 18 hours ago
Up 3% about 18 hours ago
Down 1% about 18 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatment Tumor Virotherapy Coronavirus Cytokine Inflammatory Conditions

Is ENLV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.59
52 Week Low 0.8101
Average Volume 155,029
200-Day Moving Average 1.86
50-Day Moving Average 1.40
20-Day Moving Average 1.20
10-Day Moving Average 1.06
Average True Range 0.12
RSI (14) 26.47
ADX 40.27
+DI 4.80
-DI 28.70
Chandelier Exit (Long, 3 ATRs) 1.29
Chandelier Exit (Short, 3 ATRs) 1.17
Upper Bollinger Bands 1.53
Lower Bollinger Band 0.86
Percent B (%b) 0.11
BandWidth 56.72
MACD Line -0.14
MACD Signal Line -0.11
MACD Histogram -0.0301
Fundamentals Value
Market Cap 17.28 Million
Num Shares 18.6 Million
EPS -1.47
Price-to-Earnings (P/E) Ratio -0.63
Price-to-Sales 0.00
Price-to-Book 1.35
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.08
Resistance 3 (R3) 1.06 1.00 1.06
Resistance 2 (R2) 1.00 0.96 1.01 1.05
Resistance 1 (R1) 0.96 0.93 0.98 0.98 1.04
Pivot Point 0.90 0.90 0.90 0.90 0.90
Support 1 (S1) 0.86 0.86 0.88 0.88 0.82
Support 2 (S2) 0.79 0.83 0.80 0.81
Support 3 (S3) 0.76 0.79 0.80
Support 4 (S4) 0.78